IPS - Infection Prevention Services

Home › Knowledge Hub › Antimicrobial Stewardship › Antimicrobial Stewardship in Aged Care

Pillar Page

By Lyndon Forrest, Managing Director  ·  Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors  ·  May 2026  ·  20 min read

Antimicrobial Stewardship in Aged Care

The complete guide for residential aged care providers and IPC Leads in Australia and New Zealand

TL;DR — – Quick Summary

Antimicrobial stewardship (AMS) in aged care is a structured, evidence-based program to ensure antibiotics and other antimicrobials are prescribed appropriately – reducing resistance, preventing harm, and improving resident outcomes.

In 2024, 14.4% more antimicrobials were prescribed to older Australians in residential aged care than in 2023, and 34.7% of those prescriptions ran for longer than six months (AURA 6th Report, February 2026). Almost three-quarters (74%) of aged care residents received at least one antimicrobial prescription in 2023.

Under Australia’s Strengthened Aged Care Quality Standards (Action 5.2.1), all residential aged care providers must implement an antimicrobial stewardship system from 1 November 2025. In New Zealand, AMS is mandated under NZS 8134:2021 (Nga Paerewa) Section 5.1-5.4.

antimicrobial stewardship in aged care

What Is Antimicrobial Stewardship in Aged Care?

Antimicrobial stewardship (AMS) in aged care is the ongoing, coordinated effort by a provider and its clinical caregivers to optimise the use of antimicrobial medicines – ensuring the right drug, at the right dose, for the right duration, for the right indication. The Australian Aged Care Quality and Safety Commission defines AMS as the effort to reduce the risks of increasing antimicrobial resistance (AMR) and extend the effectiveness of antimicrobial treatments in aged care services.

Antimicrobials include antibiotics, antivirals, antifungals, and antiparasitic agents. In the aged care context, the focus is predominantly on antibiotics – the class most commonly prescribed, most frequently misused, and most directly implicated in the development of antibiotic-resistant organisms like MRSA, VRE, and ESBL-producing E. coli.

AMS is not a single policy document. It is a live program of governance, clinical practice, staff education, prescriber engagement, and data monitoring that must be embedded into the daily operations of a residential aged care facility (RACF) or aged residential care (ARC) facility in New Zealand.


Why Does AMS Matter in Aged Care? The Data Is Alarming

Aged care residents are among the most vulnerable populations for both infection and antibiotic-related harm. They are older, frailer, have multiple co-morbidities, live in congregate settings, and have frequent contact with the healthcare system – all factors that both increase infection risk and amplify the consequences of inappropriate prescribing.

Key Antimicrobial Use Indicators (Australia 2023-2024)

IndicatorValueTrend
Residents receiving >=1 antimicrobial prescription annually (2023)74%High
Increase in antimicrobial prescriptions in aged care (2022-2023)+11.1%Rising
Increase in antimicrobial prescriptions in aged care (2023-2024)+14.4%Rising faster
Prescriptions lasting >6 months in aged care (2024)34.7%Concerning
Residents twice as likely to receive broad-spectrum antibiotics vs community2xHigher risk
Critical antibiotic resistance increase nationally (2024)+25.2%Alarming
Residents with signs of infection on any survey day (Aged Care NAPS 2022)3.0%–
Residents prescribed >=1 antimicrobial on any survey day (Aged Care NAPS 2022)12.5%Gap with infection rate

Source: AURA 6th Report (Australian CDC, February 2026); Aged Care NAPS 2022 (ACSQHC); Aged Care Quality and Safety Commission Clinical Alert 2024

The gap between the 3.0% of residents with signs of infection and the 12.5% prescribed an antimicrobial on any given survey day reveals the scale of the prescribing problem. Antimicrobials are being prescribed for conditions that do not meet surveillance definitions for confirmed infection.

Particularly concerning is the role of urinary tract infections (UTIs). According to a multimodal intervention study published in Trials (2022), up to 60% of antibiotic courses in RACFs are prescribed for suspected UTIs – and nearly half of that prescribing is for asymptomatic bacteriuria (ASB), a condition for which antibiotic treatment has no clinical benefit and actively promotes resistance.

Need help implementing this in your facility? The IPS Hub gives your IPC Lead instant access to ready-made policies, procedures, and audit tools — updated monthly.

Key Antimicrobial-Resistant Organisms in Aged Care Settings (Australia)

OrganismResistance TypeRACF Prevalence (2023)TrendPrimary Risk
MRSA (S. aureus)Methicillin resistance21.9% of S. aureus isolatesDown from 35% (2016)Wound infections, skin/soft tissue
VRE (Enterococcus)Vancomycin resistanceComparable to communityIncreasing nationallyUTIs, bloodstream infections
ESBL E. coliExtended-spectrum beta-lactamaseCommunity-acquired, risingStrong upward trendUTIs, sepsis
C. difficileAntibiotic-associated colitisHigh risk with prolonged AbxLinked to cefalexin useDiarrhoea, colitis, mortality

Source: APAS MDRO Update Report (ACSQHC, July 2024); AGAR ASSOP 2024 (PubMed, November 2025)

Antimicrobial Resistance in New Zealand Aged Care

In New Zealand, AMR remains a growing concern. According to IHME data for New Zealand (2019), there were 330 deaths directly attributable to AMR and approximately 1,500 deaths associated with AMR annually – with E. coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococcus aureus the leading responsible pathogens.

At the primary care level, a 2024 BPAC analysis found that 36.8% of patients enrolled with a PHO received at least one oral antibiotic dispensing in 2023 – with peak oral antibiotic prescribing occurring in patients aged 85 years and over. This disproportionately affects aged residential care residents.

Unlike Australia, New Zealand does not yet have a national aged care-specific antimicrobial prescribing survey equivalent to the Aged Care NAPS. A 2021 viewpoint article in the New Zealand Medical Journal called this an urgent gap, with authors noting that AMS efforts in New Zealand have been ‘fragmented, poorly coordinated and inadequate’ compared to Australia.


What Are the AMS Requirements Under the Current Regulatory Frameworks?

AMS compliance is now a legally enforceable requirement for aged care providers in both Australia and New Zealand. Understanding exactly what each regulatory framework demands is the starting point for any facility-level AMS program.

Australia: Strengthened Aged Care Quality Standards (2024)

The Strengthened Aged Care Quality Standards – which came into force under the Aged Care Act 2024 and Aged Care Rules 2025 – embed AMS requirements directly into Standard 5: Clinical Care. Two specific outcomes are relevant:

  • Outcome 5.2: Preventing and Controlling Infections in Delivering Clinical Care Services – requires providers to apply antimicrobial stewardship systems, minimise infection risks, and control infections when providing clinical care.
  • Action 5.2.1: The provider implements an antimicrobial stewardship system that complies with contemporary, evidence-based practice and is relevant to the service context.
Standard / ActionRequirementWho It Applies ToKey Compliance Evidence
Standard 5, Outcome 5.2Apply AMS systems; minimise infection risks; control infections in clinical careCategory 5 and 6 registered providersIPC/AMS program documentation; staff training records
Action 5.2.1Implement an AMS system complying with contemporary, evidence-based practiceAll residential care providersAMS SAT completion; Therapeutic Guidelines adherence; audit data
Action 5.2.2 Implements processes to minimise/manage infection through monitoring, review, and education All residential care providersPrescriber engagement records; NAPS participation; AB usage data review
Standard 2 (Governance)Clinical governance framework with AMS as a componentAll providersGoverning body minutes; clinical governance reports

Source: Strengthened Aged Care Quality Standards – August 2025 (Australian Government Department of Health)

New Zealand: Nga Paerewa Health and Disability Services Standard NZS 8134:2021

In New Zealand, AMS requirements for aged residential care (ARC) providers are set out in NZS 8134:2021 – Nga Paerewa Health and Disability Services Standard. Section 5 of the standard is titled ‘Te Kaupare Pokenga me te Kaitiakitanga Patu Huakita – Infection Prevention and Antimicrobial Stewardship.’

The standard defines Antimicrobial Stewardship as ‘a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.’

NZS 8134:2021 SectionTopicAMS RelevanceCertification Body
Section 5.1Infection Prevention & Control ProgramAMS integrated into IPC program governanceHealth New Zealand (Te Whatu Ora)
Section 5.2SurveillanceMonitoring antimicrobial use and resistance dataHealth New Zealand
Section 5.3EducationStaff education on appropriate antimicrobial useHealth New Zealand
Section 5.4Outbreak ManagementAMS during outbreak response to prevent escalationHealth New Zealand

Source: NZS 8134:2021 Nga Paerewa Health and Disability Services Standard; HQSC UTI Guide for Aged Residential Care

Regulatory Comparison – AMS Requirements in Australian and New Zealand Aged Care

DimensionAustraliaNew Zealand
Governing StandardStrengthened Aged Care Quality Standards (Standard 5, Action 5.2.1)NZS 8134:2021 Nga Paerewa, Sections 5.1-5.4
Legislative BasisAged Care Act 2024; Aged Care Rules 2025Health and Disability Services (Safety) Act 2001
Regulatory BodyAged Care Quality and Safety CommissionHealth New Zealand (Te Whatu Ora)
AMS Defined AsOngoing effort to reduce AMR risk and extend effectiveness of antimicrobial treatmentsCoordinated program promoting appropriate antimicrobial use and reducing resistance
IPC Lead RequiredYes – Action 4.2.1(a) requires an appropriately qualified IPC LeadYes – IPC Lead role required under NZS 8134
National Prescribing SurveyAged Care NAPS (annual, national)No equivalent national aged care-specific survey
Key Self-Assessment ToolAMS SAT (Residential Aged Care Services tool)HQSC UTI Guide and IPC resources

Source: Aged Care Quality and Safety Commission; NZS 8134:2021; Australian Government Department of Health and Aged Care


What Are the Core Components of an AMS Program for a RACF?

An effective AMS program for a residential aged care facility is not a single policy – it is a structured, multi-component system. The ACSQHC guidance for aged care (November 2024) identifies the following core components, each of which should be documented, operationalised, and regularly reviewed.

AMS Program ComponentWhat It Requires in PracticeKey Resource or Tool
1. Governance and LeadershipA designated AMS lead (often the IPC Lead or Clinical Nurse); governing body oversight; AMS integrated into clinical governance frameworkAMS SAT User Guide (ACQSC)
2. Prescriber EngagementRegular communication with GPs, NPs, and visiting specialists about prescribing patterns; clinical pathways for common infections; access to Therapeutic GuidelinesTherapeutic Guidelines Antibiotic (eTG); GP engagement letters
3. Antimicrobial Use MonitoringTracking prescription starts, durations, indications, and outcomes; participation in the Aged Care NAPS; regular review of prescriptions exceeding 7 days or 6 monthsAged Care NAPS (naps.org.au); AMS SAT audit tool
4. Clinical Decision SupportClinical pathways for UTI, respiratory infections, skin/soft tissue infections; urine dipstick protocols; specimen collection guidance before initiating antimicrobials‘To Dip or Not to Dip’ toolkit; ACSQHC UTI clinical pathway
5. Staff Education and CompetencyAnnual AMS training at orientation and yearly refresh; competency assessment for nurses, PCWs, and clinical staff; outbreak scenario trainingIPS Hub AMS training modules; ACIPC resources
6. Consumer CommunicationResidents, families, and carers informed about antimicrobial use decisions, how to identify ineffective treatment, and adverse effectsTDONTD consumer flyer ‘Do you need antibiotics?’; multilingual versions
7. Antimicrobial Review and Stop DatesEvery antimicrobial prescription must document indication, review date, and stop date; prescriptions >7 days require a documented clinical reviewMedication chart documentation standards; AMS SAT indicators
8. Audit and Quality ImprovementRegular audit of prescribing against Therapeutic Guidelines; review of outlier prescriptions (e.g., cefalexin prescribed for conditions outside indications); QI cyclesAMS SAT; Aged Care NAPS facility-level reporting

Source: ACSQHC Guidance for AMS CCS in Aged Care (November 2024); Aged Care Quality and Safety Commission AMS SAT


Why Is UTI Management the Single Biggest AMS Challenge in Aged Care?

Urinary tract infections (UTIs) account for up to 60% of antibiotic prescriptions in Australian residential aged care facilities – making UTI management the single most impactful area for AMS intervention. The clinical challenge is that aged care residents frequently have asymptomatic bacteriuria (ASB) – bacteria in the urine without symptoms of infection – which is common, benign, and should not be treated with antibiotics.

The critical distinction between ASB and symptomatic UTI requires clinical assessment, not just a positive urine dipstick result. Urine dipstick testing for residents with no urinary symptoms has been consistently identified as a key driver of inappropriate antibiotic prescribing in aged care. The ACSQHC’s ‘To Dip or Not to Dip’ (TDONTD) program was specifically developed to address this.

UTI Clinical Decision-Making: When to Treat and When NOT to Treat

Clinical ScenarioAppropriate ResponseAMS Action Required
Resident with positive dipstick – no urinary symptomsDo NOT treat – this is likely ASBEducate staff and prescribers; document as ASB; no specimen collection
Resident with dysuria, frequency, new incontinence (no catheter)Collect MSU before starting antibiotics; prescribe per Therapeutic GuidelinesDocument indication: set 7-day review date; use first-line AB 
Catheterised resident – positive dipstick, no new symptomsDo NOT treat – catheter-associated bacteriuria is expectedReview catheter necessity; educate staff; no antibiotics unless systemic signs
Resident with systemic signs (fever, rigors, confusion, tachycardia)Urgent clinical review; blood cultures if possible; escalate to hospital if appropriateStart antibiotics empirically per TG; document and review at 48-72 hours
Resident on long-term antibiotic prophylaxisReview prophylaxis indication – rarely recommended in aged careFlag for prescriber review; taper where clinically safe

Source: ACSQHC ‘To Dip or Not to Dip’ Clinical Pathway; Therapeutic Guidelines Antibiotic; Aged Care NAPS 2022

The 2022 Aged Care NAPS found that 37.6% of all antimicrobial prescriptions in RACFs had commenced more than six months prior – with clotrimazole (37.3%), cefalexin (14.5%), and Kenacomb (6.2%) being the most common long-duration agents. Of prescriptions started within the previous six months, 31.5% had already exceeded seven days without a documented review – a direct target for AMS intervention.


Why Is Cefalexin the Most Prescribed Antibiotic in Aged Care – and Why Is This a Problem?

Cefalexin (a broad-spectrum, first-generation cephalosporin) has consistently been one of the most commonly prescribed systemic antibiotics in Australian aged care homes across all Aged Care NAPS surveys. The 2022 Aged Care NAPS found cefalexin was the most prescribed systemic antimicrobial at 19.5% of all prescriptions, primarily for cystitis (48.4% of cefalexin prescriptions) and wound infections (33.9%).

The clinical concern is that cefalexin is not the first-line recommended antibiotic for the most common aged care infections:

  • For uncomplicated cystitis (UTI) – Therapeutic Guidelines Antibiotic recommends trimethoprim or nitrofurantoin as first-line; cefalexin is a second-line option only when first-line agents are contraindicated or resistant.
  • For skin/soft tissue infections – Flucloxacillin is preferred for confirmed Staphylococcus aureus infections; cefalexin is appropriate for mixed infections.

High cefalexin use drives resistance in two ways: it selects for resistant organisms directly, and its broad-spectrum activity disrupts the resident’s normal flora, increasing susceptibility to Clostridioides difficile colitis – a serious, potentially fatal complication in frail aged care residents.

IPS Practice Note – Cefalexin Monitoring Facilities should monitor their cefalexin prescription rates as a key AMS performance indicator. A high proportion of cefalexin for cystitis is a red flag that should trigger a review of local prescribing practices against Therapeutic Guidelines. Consider a structured conversation with attending GPs about first-line antibiotic choices for UTI.

How Do AMS and IPC Work Together?

Antimicrobial stewardship and infection prevention and control (IPC) are distinct disciplines with overlapping purposes – and their combined effect on antimicrobial resistance is greater than either achieves alone. The Aged Care Quality and Safety Commission explicitly states that ‘combined strategies of antimicrobial stewardship and infection prevention and control are the most effective in reducing antimicrobial use.’

The relationship operates in both directions:

  • Strong IPC reduces the incidence of infections – fewer infections mean fewer prescriptions needed, reducing selection pressure for resistance.
  • Strong AMS reduces the volume and breadth of antimicrobial use – lower antimicrobial pressure means resistant organisms are less likely to emerge and spread within the facility.
  • When an outbreak occurs, AMS prevents the cascade of precautionary prescribing that often follows without a confirmed diagnosis – a pattern that accelerates resistance without clinical benefit.
AMS ActivityIPC LinkCombined Outcome
Reducing unnecessary UTI antibioticsLower C. difficile risk; better gut flora resilienceFewer GI outbreaks; reduced MDRO colonisation
Appropriate specimen collection before prescribingAccurate microbiological diagnosis; targeted treatmentReduced broad-spectrum use; better outbreak characterisation
Review of long-term prophylactic antibioticsReduces colonisation pressure from resistant organismsLower MRSA and VRE carriage rates in the facility
Staff education on when NOT to treatSupports IPC triage decisions and reduces inappropriate isolationLess unnecessary clinical disruption; better resident experience
Participation in Aged Care NAPSIdentifies facility-level infection trends and hot-spotsTargeted IPC and AMS interventions where most needed
IPC Lead oversight of AMS programSingle accountable leader for both programsIntegrated governance; streamlined audit and reporting

Source: Aged Care Quality and Safety Commission; ACSQHC AMS in Aged Care Guidance (November 2024)

Note for NZ Providers New Zealand does not yet have a national aged care-specific antimicrobial prescribing survey equivalent to Australia’s Aged Care NAPS. This means NZ facilities must proactively build their own local data monitoring systems to demonstrate compliance with NZS 8134:2021 and to track AMS program performance. The IPS Hub provides a practical surveillance and audit framework designed specifically for NZ ARC settings – including AMS tracking tools, prescribing audit templates, and staff education modules aligned to NZS 8134:2021.

How Do You Set Up an AMS Program in Your Aged Care Facility?

For IPC Leads and clinical managers implementing or strengthening AMS in a RACF or ARC, the following stepped approach reflects the ACSQHC guidance and Aged Care NAPS recommendations.

StepActionTools and Resources
Step 1Baseline assessment – complete the AMS SAT to identify current gaps against the AMS Clinical Care StandardAMS SAT and User Guide (agedcarequality.gov.au)
Step 2Assign AMS leadership – identify a designated AMS lead (IPC Lead, Clinical Manager, or CNS) and document their roleAMS SAT governance section; IPS Hub IPC Lead role guide
Step 3Engage prescribers – meet with the facility’s GPs and NPs to share local prescribing data and agree on clinical pathways for common infectionsTherapeutic Guidelines Antibiotic (eTG); ACSQHC GP letter template
Step 4Implement UTI clinical pathway – roll out the TDONTD program to prevent inappropriate urine dipstick testing and antibiotic use‘To Dip or Not to Dip’ full implementation toolkit (agedcarequality.gov.au)
Step 5Review long-duration prescriptions – identify all antimicrobial prescriptions exceeding 7 days and flag for clinical reviewAged Care NAPS participation; medication chart audit template
Step 6Educate staff – deliver AMS training covering: what AMS is, when NOT to request a urine dipstick, recognition of infection vs. colonisation, and how to escalate concernsIPS Hub AMS staff education module; ACSQHC TDONTD staff education case studies
Step 7Educate residents and families – provide consumer-friendly information about when antibiotics are needed and the risk of overuseTDONTD consumer flyer (available in 25 languages)
Step 8Monitor and report – establish a monthly or quarterly antimicrobial use review as part of clinical governance; report to the governing bodyAMS SAT audit tool; Aged Care NAPS facility-level report; IPS surveillance dashboard

Source: ACSQHC Guidance for AMS CCS in Aged Care (2024); Aged Care NAPS; To Dip or Not to Dip Implementation Guide

Explore the Full AMS Topic Cluster

This pillar page provides an overview of antimicrobial stewardship in aged care. For detailed implementation guidance, step-by-step tools, and compliance checklists, explore the cluster articles in this topic group:

Cluster ArticleWhat You Will LearnFor Whom
1.1: AMS Program Setup Guide for RACFsStep-by-step setup of an AMS program from baseline audit to full implementationIPC Leads, Clinical Managers, Facility Managers
1.2: AMS Compliance Under the New Aged Care Quality StandardsExactly what Actions 5.2.1 and 5.2.2 require, how auditors will assess compliance, and how to document evidenceIPC Leads, Quality Managers, Directors of Care
1.3: Setting Up an IPC Committee for AMSHow to establish and run an IPC Committee that governs both IPC and AMSIPC Leads, Clinical Governance Leads
1.4: IPC Lead Toolkit – Daily, Weekly, Monthly TasksComplete task schedule and resource list for IPC Leads covering both IPC and AMS dutiesIPC Leads
1.5: AMS and IPC – How They Work TogetherPractical guide to integrating AMS and IPC governance, reporting, and clinical practice at facility levelIPC Leads, Clinical Governance Leads

AMS & IPC Training: Stop the Spread — join our expert-led workshop combining Antimicrobial Stewardship and IPC strategies designed specifically for aged care facilities.

Frequently Asked Questions

What is antimicrobial stewardship in aged care?

Antimicrobial stewardship (AMS) in aged care is a structured program to ensure antibiotics and other antimicrobials are prescribed appropriately – for the right indication, at the right dose, for the right duration. It aims to reduce antimicrobial resistance, prevent resident harm from side effects, and improve clinical outcomes. In Australian RACFs, AMS is a mandatory component of the Strengthened Aged Care Quality Standards (Action 5.2.1). In New Zealand ARC facilities, it is required under NZS 8134:2021.

What is an antimicrobial stewardship program?

An antimicrobial stewardship program (AMS program) is a coordinated set of governance, clinical, educational, and monitoring activities designed to optimise antimicrobial use in a healthcare setting. In aged care, it includes: a designated AMS lead, clinical pathways for common infections, staff education, prescriber engagement, regular audits of antimicrobial prescriptions against Therapeutic Guidelines, and resident/family communication. The ACSQHC has published specific guidance for implementing the AMS Clinical Care Standard in aged care settings (November 2024).

What are the antimicrobial stewardship requirements under the new Aged Care Quality Standards?

Under the Strengthened Aged Care Quality Standards (effective 1 November 2025), Standard 5: Clinical Care – Outcome 5.2 requires providers to apply antimicrobial stewardship systems and minimise infection risks. Action 5.2.1 specifically requires providers to implement an AMS system that complies with contemporary, evidence-based practice and is appropriate to the service context. The Aged Care Quality and Safety Commission assesses this at accreditation.

What is the most common driver of inappropriate antibiotic prescribing in aged care?

The most common driver is the misdiagnosis and treatment of asymptomatic bacteriuria (ASB) as a urinary tract infection (UTI). ASB – bacteria in the urine without symptoms – is common in older adults and does not require antibiotic treatment. Positive urine dipstick results in residents without urinary symptoms lead to unnecessary prescribing that promotes resistance and C. difficile infection. The ACQSC‘s ‘To Dip or Not to Dip’ (TDONTD) program is the evidence-based intervention designed to address this in RACFs.

What is antimicrobial stewardship in New Zealand aged care?

In New Zealand, antimicrobial stewardship (AMS) in aged residential care (ARC) is governed by NZS 8134:2021 – Nga Paerewa Health and Disability Services Standard, Sections 5.1 to 5.4. This standard requires certified ARC providers to implement a coordinated AMS program that promotes appropriate antimicrobial use, improves resident outcomes, and reduces microbial resistance. Practical implementation resources include the HQSC UTI guide for aged residential care and BPAC NZ prescribing guidance. Unlike Australia, NZ does not yet have a national aged care-specific antimicrobial prescribing survey.

How does antimicrobial stewardship relate to antimicrobial resistance?

Antimicrobial resistance (AMR) develops when bacteria, fungi, viruses, or parasites evolve to withstand the medicines used to treat them – driven by the selection pressure of antimicrobial use. AMS directly addresses AMR by reducing unnecessary and inappropriate antimicrobial use, which is the primary driver of resistance. In Australia, critical AMR increased by 25.2% in 2024, while 14.4% more antimicrobials were prescribed to aged care residents than in 2023 – highlighting the direct relationship between prescribing volumes and resistance trends (AURA 6th Report, February 2026).

Which antibiotics are most commonly prescribed in Australian residential aged care?

According to the 2022 Aged Care NAPS, the most commonly prescribed antimicrobials in Australian RACFs were: clotrimazole (21.7% – topical antifungal for tinea), cefalexin (19.5% – primarily for cystitis and wound infections), and chloramphenicol (6.3% – topical for eye infections). Cefalexin’s dominance as the leading systemic antibiotic is a key AMS concern, as it is not the first-line recommended agent for the most common aged care infections under Therapeutic Guidelines.

References and Further Reading

  • Australian Centre for Disease Control (CDC). Sixth Australian Report on Antimicrobial Use and Resistance in Human Health (AURA 6th Report). Canberra: CDC; February 2026.
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). Guidance for Implementation of the AMS Clinical Care Standard in Aged Care. Sydney: ACSQHC; November 2024.
  • Australian Commission on Safety and Quality in Health Care (ACSQHC). APAS Report: An Update of Resistance Trends in Multidrug-Resistant Organisms. Sydney: ACSQHC; July 2024.
  • Aged Care Quality and Safety Commission. Antimicrobial Stewardship (AMS). agedcarequality.gov.au
  • Aged Care Quality and Safety Commission. Standard 5: Clinical Care – Strengthened Aged Care Quality Standards. Updated October 2025.
  • Australian Government Department of Health and Aged Care. Strengthened Aged Care Quality Standards – August 2025.
  • National Antimicrobial Prescribing Survey (NAPS). Aged Care NAPS 2022 Results. Canberra: ACSQHC; 2023.
  • Standards New Zealand. NZS 8134:2021 Nga Paerewa Health and Disability Services Standard. Wellington: Standards NZ; 2021.
  • Health Quality and Safety Commission New Zealand (HQSC). UTI Guide for Aged Residential Care. Wellington: HQSC.
  • Ministry of Health New Zealand. New Zealand Antimicrobial Resistance Action Plan. Wellington: MoH.
  • BPAC New Zealand. Revisiting Antibiotic Use in New Zealand: How Does Your Prescribing Compare? BPAC; June 2024.
  • Gardiner SJ, et al. Antimicrobial stewardship in human healthcare in Aotearoa New Zealand. NZ Med J. 2021;134(1544).
  • Russo PL, et al. A multimodal intervention to optimise antimicrobial use in residential aged care facilities. Trials. 2022;23:436.
IPS - Infection Prevention Services

About the Author

Lyndon Forrest is the Managing Director of Bug Control — Infection Prevention Services, with over 30 years’ experience supporting aged care facilities across Australia and New Zealand with infection prevention, antimicrobial stewardship, and accreditation readiness.

Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors

AMS & IPC Training

Stop the Spread — join our expert-led workshop combining Antimicrobial Stewardship and IPC strategies designed specifically for aged care facilities.

Ready to Strengthen Your Facility’s Infection Prevention?

The IPS Hub provides aged care facilities across Australia and New Zealand with continuously updated IPC policies, AMS tools, outbreak management resources, and direct support from experienced IPC professionals.